Institutional members access full text with Ovid®

Share this article on:

When and How to Perform a Biopsy on a Chronic Wound

Alavi, Afsaneh MD; Niakosari, Firouzeh MD, FRCPC; Sibbald, R. Gary BSc, MD, MEd, FRCPC (Med Derm), MACP, FAAD, FAPWCA

Advances in Skin & Wound Care: March 2010 - Volume 23 - Issue 3 - pp 132-140
doi: 10.1097/01.ASW.0000363515.09394.66
Features: Clinical Management Extra

PURPOSE: To enhance the learner's competence with knowledge of biopsy techniques and when to perform biopsies on specific chronic wounds.

TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care.

OBJECTIVES: After participating in this educational activity, the participant should be better able to:

1. Distinguish between different types of chronic wounds that require biopsies.

2. Apply knowledge of biopsy techniques to obtain quality results.

3. Analyze various types of chronic wounds to determine the appropriate type of biopsy needed.

In this continuing education activity, the authors emphasize the role of wound biopsy in the management of various chronic wounds, present the available techniques for wound biopsy, and identify the appropriate location for the biopsy based on the underlying etiologies.

Afsaneh Alavi, MD • Dermatology Resident/Former Wound Healing Fellow • Department of Medicine (Dermatology) • University of Toronto, Ontario, Canada

Firouzeh Niakosari, MD, FRCPC • Pathology/Dermatology Physician • Scarborough General Hospital, Toronto

R. Gary Sibbald, BSc, MD, MEd, FRCPC (Med Derm), MACP, FAAD, FAPWCA • Professor of Public Health Science and Medicine • University of Toronto • Director • International Interprofessional Wound Care Course & Masters of Science in Community Health • Dalla Lana School of Public Health Sciences • University of Toronto • President • World Union of Wound Healing Societies • Clinic Associate Editor • Advances in Skin & Wound Care • Ambler, PA

Dr Alavi has disclosed that she has no significant relationships with or financial interest regarding this educational activity. Dr Niakosari has disclosed that she has no significant relationships with or financial interest regarding this educational activity. Dr Sibbald has disclosed that he is/was a recipient of grant/research funding from 3M, BSN Medical, Coloplast, Gaymar, KCI, Johnson & Johnson (Systagenix), and Mölnlycke; is was a consultant/advisor to 3M, BSN Medical, Coloplast, Covidien, Gaymar, KCI, Johnson & Johnson (Systagenix), Mölnlycke, and the Registered Nurses Association of Ontario, and is/was a member of the speaker's bureau for 3M, BSN Medical, Coloplast, Gaymar, KCI, Johnson & Johnson (Systagenix), and MÖlnlycke. All staff, faculty, including spouses/partners (if any) in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

This continuing educational activity will expire for physicians on March 31, 2011.

© 2010 Lippincott Williams & Wilkins, Inc.